Abiopharma

U.S. Food and Drug Administration (FDA) Grants Priority Review to Bristol Myers Squibbs Application for Opdivo® (nivolumab) Plus Chemotherapy Combination for Classical Hodgkin Lymphoma

U.S. Food and Drug Administration (FDA) Grants Priority Review to Bristol Myers Squibbs Application for Opdivo® (nivolumab) Plus Chemotherapy Combination for Classical Hodgkin Lymphoma

Lillys triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial

Zomedica Announces Collaboration with Prime Video as Assisi Loop(R) Products Appear in New Holiday Film Merv

Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology

Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology USA - English Deutschland - English France - Français

IDEAYA Biosciences Completes Targeted Full Enrollment in Randomized Pivotal Phase 2/3 Trial (OptimUM-02) of Darovasertib in Combination with Crizotinib in First-line HLA*A2-Negative Metastatic Uveal Melanoma

Arcline to Sell Medical Manufacturing Technologies to Perimeter Solutions for $685 Million

Certara Appoints Jon Resnick as Chief Executive Officer

Guardant Health e il Policlinico Gemelli lanciano in Italia un servizio di test di biopsia liquida in ospedale